期刊文献+

肝欣液体外抗HBV活性及HBsAg抑制作用的实验研究 被引量:2

EXPERIMENTAL STUDY ON THE ROLE OF GAN XIN LIQID IN RESISTING HBV ACTIVTTY AND INHIBITTNG HBSAG
下载PDF
导出
摘要 目的:探讨中药复方肝欣液体外抗乙肝病毒(HBV)活性及抑制乙肝表面抗原(HBsAg)的作用。方法:采用2.2.15细胞培养测定肝欣液对HBV的活性以及采用反相被动血凝抑制试验(RPHI)对肝欣液抗HBsAg进行实验观察。结果:肝欣液最高浓度为5~7μl/ml,作用7天和14天时,对2.2.15细胞HBsAg分泌抑制率分别为55.12%~57.48%和60.98%~71.34%,并可使培养上清中HBVDNA的量减少;浓度为7μl/ml,作用14天时对乙肝e抗原(HBeAg)分泌抑制率为50.28%,并可使培养上清HBVDNA的量减少,肝欣液500μl/ml对HBsAg有显著抑制作用,与阴性对照组比较凝集效价下降3~4个倍比度(P<0.01)。结论:肝欣液浓度为5~7μl/ml时,在体外细胞培养中,具有一定的抗HBV活性,并对HBsAg有良好的抑制作用。 Objedive: To inquire into the role of Gan Xin Liquid in resishng hepatitis B Virus(HBV) activity and inhibihng hepatis B surface antigen(HBsAg). Mathod: Cell - 2.2. 15 eulture was adopted to test the role of Gan Xin Liquid in resisting HBV activity, and reverse passive hemagglutination inhibition(RPHI) test was made to observe the effect of Gan Xin Liquid in resisting HBsAg. Results: When the maximum density of Gan Xin Liquid amounted to 5~7μl/ml, and acted for seven days and fourteen days, the inhibiting rates of HBsAg secretion of cell - 2. 2. 15 were 55. 12%~ 57 .48% and 60.98% ~ 71. 34% aspetively, and the amount of HBV DNA in culture supernatant fluid could be brought down.When its density was 7μl/ml and acted for fourteen days,its inhibiting rate of HBeAg secretion was 50.28% and it made the amount of HBV DNA in the culture supematan fluid cut down. 500μl/ml of Gan Xin Liquid was of significant effect on HBsAg;compared with the negative control group,the agglutination titer dereased three to fourfold, which had a significant difference (P <0.01). Conclusion: When the density of Gan Xin Liquid is 5 ~ 7μl/ml,it is of certain effect on resisting HBV activity in cell culture in vitro and it also has a better cffect on inhibiting HBsAg.
出处 《泸州医学院学报》 1999年第6期475-477,共3页 Journal of Luzhou Medical College
关键词 肝欣液 乙型肝炎病毒 乙型肝炎 HBSAG 实验研究 Gan Xin Liquid Hepatitis B virus Cell-2.2.15
  • 相关文献

参考文献1

二级参考文献1

  • 1Chan Y,Shanghai J Chin Med,1982年,3卷,30页

共引文献27

同被引文献59

  • 1谢华娣,陈鸿珊.十味溪黄草颗粒对乙型肝炎病毒的体外抑制作用[J].广东药学,2004,14(6):60-63. 被引量:9
  • 2彭齐荣,李灼亮,涂荫国,黄振国,覃贵伦,王宝奎,谢庆.肝毒清对HBV转染细胞表达功能的抑制[J].中西医结合肝病杂志,1995,5(2):21-22. 被引量:8
  • 3章瑜,薛智谋,徐璎,李建祥,周慧英,王禹斌.“蚂蚁乙肝宁”抗乙型肝炎病毒的实验研究[J].上海实验动物科学,1995,15(2):102-104. 被引量:1
  • 4范涛,傅希贤,张国庆,张乃临.中草药抗乙型肝炎病毒活性及其作用机理体外实验研究[J].中华实验和临床病毒学杂志,1996,10(1):27-30. 被引量:27
  • 5Yokosukao, Omata M, Imazeki F, et al. Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interfere on treatment: analysis of intra hepatitic replicative hepatitis B virus DNA[J ]. Hepatology, 1985,5:728~ 734.
  • 6Evens F, Main J, Honkoo P, et al. Lamivud in etherapy for chronic hepatitis B: a six month and omized dose ranging study[J]. Gastoenterology, 1997,113:1258~ 1263.
  • 7Fu L, Cheng YC. Role of additional mutations outside the YMDD motif of hepatitis B virus polymerase in L. SddC (3TC)resistance[J]. Biochem Pharmacol, 1998,55:1567~1572.
  • 8Wright TL,Lau JY. Clinical aspects of hepatitis B virus infection[ J ]. Lancet, 1993,342:1340 - 1344.
  • 9Lai CL,Chien RN,Leung NW, et al. Alyeartrial of lamivudine for chronic hepatitis B [J]. Nengl J Med, 1998,339:61~68.
  • 10Sell MA ,Chen ML,Acs G. Production of hepatitis B virus particles in HePG2 cells transfected with cloned hepatitis B virus DNA[J]. Pro Notl Acad Sci USA, 1987,84:1005~1009.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部